Novo Integrated Sciences Analysis

Novo OTC Stock Analysis Notes

The company has price-to-book ratio of 0.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Novo Integrated Sciences recorded a loss per share of 0.41. The entity last dividend was issued on the 1st of February 2021. The firm had 1:10 split on the 7th of November 2023. Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc. Novo Integrated operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.The quote for Novo Integrated Sciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Novo Integrated Sciences contact Robert Mattacchione at 206 617 9797 or learn more at https://www.novointegrated.com.

Novo Integrated Sciences Investment Alerts

Novo Integrated Sciences Upcoming and Recent Events

Novo Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Integrated's market, we take the total number of its shares issued and multiply it by Novo Integrated's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novo Profitablity

The company has Profit Margin (PM) of (1.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.8.

Technical Drivers

As of the 22nd of November, Novo Integrated secures the Standard Deviation of 15.88, risk adjusted performance of (0.1), and Mean Deviation of 7.53. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novo Integrated Sciences, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for Novo Integrated, which can be compared to its peers in the industry. Please verify Novo Integrated Sciences market risk adjusted performance and treynor ratio to decide if Novo Integrated Sciences is priced some-what accurately, providing market reflects its recent price of 0.0441 per share. As Novo Integrated Sciences appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.

Novo Integrated Sciences Price Movement Analysis

Novo Integrated Sciences Insider Trading Activities

Novo Integrated Outstanding Bonds

Novo Integrated Predictive Daily Indicators

Novo Integrated Forecast Models

Novo Integrated's time-series forecasting models are one of many Novo Integrated's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novo Integrated's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Novo Integrated prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novo shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Novo Integrated. By using and applying Novo OTC Stock analysis, traders can create a robust methodology for identifying Novo entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.